semaglutide ckd Effects of on Chronic Kidney Disease in Patients with Type 2 Diabetes Evolution of CKD risk after
Description
the 2023 Summary of Modifications and Explanatory Notes
Zheng YJ, Soegiharto C, Au HCT, Valentino K, Le GH, Wong S, et al
Important considerations for ongoing management: Your prescriber may need to adjust your dose, switch to an alternative GLP-1 medicine, or investigate other potential causes of digestive symptoms
Ueda P, Soderling J, Wintzell V, Svanstrom H, Pazzagli L, Eliasson B, Melbye M, Hviid A, Pasternak B
or severe nausea, vomiting, or diarrhea leading to dehydration
